{
 "PrintNo":"A7920","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-04-11T15:20:48.53799Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-04-11","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2025-04-11","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":1536,"Name":"Matthew Slater","Short":"SLATER"}],
 "Title":"Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology",
 "Summary":"Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.",
 "LawSection":"Insurance Law","LawCode":"Add ยง3216-a, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to the use of abuse-deterrent technology for opioids as a mechanism for reducing abuse and diversion of opioid drugs",
 "SameAsPrintNo":"S6937-2025","PreviousVersions":["S6962-2015","S7009-2017","S3272-2019","S6180-2021","S4754-2023"]
}